News | Artificial Intelligence | July 03, 2019

Company now shifts focus to launch of breast cancer screening artificial intelligence solution

Therapixel Appoints Matthieu Leclerc-Chalvet as CEO

July 3, 2019 — Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu Leclerc-Chalvet as chief executive officer on June 14, 2019. This follows a 5 million euros series A fundraising, and the appointment of Sacha Loiseau as chairman of the board. Leclerc-Chalvet is also joining the board of directors.

Leclerc-Chalvet brings 30 years of experience in the development and commercialization of medical devices. After 20 years abroad, working for multinational organizations as well as start-ups, he chose to return to France to share his experience with Therapixel. Until now, Leclerc-Chalvet was managing director of Mirada Medical, a British company specialized in medical imaging software, where he orchestrated a pivot towards AI, leading to the launch of the first AI software in radiotherapy.

Leclerc-Chalvet declared, “I am thrilled to join a team of such technical and scientific excellence, and to bring my strategic and operational expertise in adoption of medical technology innovation globally.” 

This appointment allows Therapixel co-founder and interim CEO Pierre Fillard to focus on his role of chief scientific officer (CSO). He will work alongside Leclerc-Chalvet on completing the AI breast cancer screening product and going through the regulatory approvals leading to the commercial launch.

Read the article "Therapixel Wins the Digital Mammography Challenge"

For more information: www.therapixel.com

Related Content

News | Mammography

October 27, 2021 — As part of Breast Cancer Awareness Month, Penn Medicine will be providing free breast cancer ...

Time October 27, 2021
arrow
News | Artificial Intelligence

October 27, 2021 — Scientists from Skoltech, Philips Research, and Goethe University Frankfurt have trained a neural ...

Time October 27, 2021
arrow
News | Artificial Intelligence

October 27, 2021 — Carestream Health will highlight the imaging and workflow value of artificial intelligence (AI) in ...

Time October 27, 2021
arrow
News | Radiation Oncology

October 25, 2021 — A new study shows that system-level changes to the way cancer care is delivered can also eliminate ...

Time October 25, 2021
arrow
News | Radiation Therapy

October 22, 2021 — At this year’s ASTRO 2021 event, GE Healthcare will showcase over 15 innovative multi-modality ...

Time October 22, 2021
arrow
News | Women's Health

October 20, 2021 — In conjunction with ongoing Breast Cancer Awareness Month efforts, Hologic, Inc., an innovative ...

Time October 20, 2021
arrow
News | Mammography

October 19, 2021 — If Black women begin mammography screening every other year starting at age 40, breast cancer deaths ...

Time October 19, 2021
arrow
News | Artificial Intelligence

October 19, 2021 — South Korean artificial intelligence (AI) developer, VUNO Inc., announced that the company closed a ...

Time October 19, 2021
arrow
News | Ultrasound Imaging

October 15, 2021 — NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, introduces the V8; a high-end ...

Time October 15, 2021
arrow
News | Ultrasound Women's Health

October 14, 2021 — In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto ...

Time October 14, 2021
arrow
Subscribe Now